A study published in Obstetrics & Gynecology reveals that there are no medical benefits found in transvaginal mesh use over alternative surgeries. The 3-year success rates of transvaginal mesh patients were no better than traditional methods of curing pelvic organ prolapse.
In addition to not providing better success rates, transvaginal mesh has been linked to several severe side effects. Women who received transvaginal mesh implants have complained of limited mobility, tissue damage and pain during intercourse.
Thousands of women have filed transvaginal mesh lawsuits alleging that manufacturers such as Johnson & Johnson, Boston Scientific and C.R. Bard released defective devices. Several companies issued transvaginal mesh recalls after studies found that patients were suffering severe complications.